Curis (CRIS) EPS (Basic) Growth (5y) (2015 - 2026)
Curis (CRIS) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Curis | 3.36 Mn | -2.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.85% |
| Dec 31, 2025 | 27.91% |
| Sep 30, 2025 | 25.79% |
| Jun 30, 2025 | 27.49% |
| Mar 31, 2025 | 26.04% |
| Dec 31, 2024 | 23.99% |
| Sep 30, 2024 | 14.36% |
| Jun 30, 2024 | 13.52% |
| Mar 31, 2024 | 70.97% |
| Dec 31, 2023 | 9.74% |
| Sep 30, 2023 | 12.36% |
| Jun 30, 2023 | 13.12% |
| Mar 31, 2023 | 17.67% |
| Dec 31, 2022 | 16.21% |
| Sep 30, 2022 | 23.11% |
| Jun 30, 2022 | 18.44% |
| Mar 31, 2022 | 20.00% |
| Dec 31, 2021 | 18.82% |
| Sep 30, 2021 | 35.35% |
| Jun 30, 2021 | 21.83% |